395 related articles for article (PubMed ID: 30009949)
1. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
Sandland J; Malatesti N; Boyle R
Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
[TBL] [Abstract][Full Text] [Related]
2. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy.
Li J; Wang X; Zheng D; Lin X; Wei Z; Zhang D; Li Z; Zhang Y; Wu M; Liu X
Biomater Sci; 2018 Jun; 6(7):1834-1845. PubMed ID: 29786715
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
5. Porphyrin as Diagnostic and Therapeutic Agent.
Tsolekile N; Nelana S; Oluwafemi OS
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340553
[TBL] [Abstract][Full Text] [Related]
6. Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights.
Feng G; Liu B
Acc Chem Res; 2018 Jun; 51(6):1404-1414. PubMed ID: 29733571
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
8. Photochemical /Photocytotoxicity Studies of New Tetrapyrrolic Structures as Potential Candidates for Cancer Theranostics.
Ferreira LFV; Machado IF; Gama A; Socoteanu RP; Boscencu R; Manda G; Calhelha RC; Ferreira ICFR
Curr Drug Discov Technol; 2020; 17(5):661-669. PubMed ID: 30973109
[TBL] [Abstract][Full Text] [Related]
9. Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management.
Almeida-Marrero V; van de Winckel E; Anaya-Plaza E; Torres T; de la Escosura A
Chem Soc Rev; 2018 Oct; 47(19):7369-7400. PubMed ID: 30152500
[TBL] [Abstract][Full Text] [Related]
10. A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection.
Schmitt J; Heitz V; Sour A; Bolze F; Kessler P; Flamigni L; Ventura B; Bonnet CS; Tóth É
Chemistry; 2016 Feb; 22(8):2775-86. PubMed ID: 26791109
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
12. An NIR-II-Emissive Photosensitizer for Hypoxia-Tolerant Photodynamic Theranostics.
Li L; Shao C; Liu T; Chao Z; Chen H; Xiao F; He H; Wei Z; Zhu Y; Wang H; Zhang X; Wen Y; Yang B; He F; Tian L
Adv Mater; 2020 Nov; 32(45):e2003471. PubMed ID: 33029855
[TBL] [Abstract][Full Text] [Related]
13. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
14. Theranostics with photodynamic therapy for personalized medicine: to see and to treat.
Wang Y; Staudinger JN; Mindt TL; Gasser G
Theranostics; 2023; 13(15):5501-5544. PubMed ID: 37908729
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers.
Zhao L; Kim TH; Kim HW; Ahn JC; Kim SY
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():611-622. PubMed ID: 27287160
[TBL] [Abstract][Full Text] [Related]
16. Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin.
Ferrand Y; Bourré L; Simonneaux G; Thibaut S; Odobel F; Lajat Y; Patrice T
Bioorg Med Chem Lett; 2003 Mar; 13(5):833-5. PubMed ID: 12617902
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible conjugated fluorenylporphyrins for two-photon photodynamic therapy and fluorescence imaging.
Shi L; Nguyen C; Daurat M; Dhieb AC; Smirani W; Blanchard-Desce M; Gary-Bobo M; Mongin O; Paul-Roth C; Paul F
Chem Commun (Camb); 2019 Oct; 55(81):12231-12234. PubMed ID: 31553001
[TBL] [Abstract][Full Text] [Related]
18. Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent.
Harmatys KM; Overchuk M; Chen J; Ding L; Chen Y; Pomper MG; Zheng G
Bioconjug Chem; 2018 Nov; 29(11):3746-3756. PubMed ID: 30350576
[TBL] [Abstract][Full Text] [Related]
19. A first comparative study of purpurinimide-based fluorinated vs. nonfluorinated photosensitizers for photodynamic therapy.
Gryshuk AL; Graham A; Pandey SK; Potter WR; Missert JR; Oseroff A; Dougherty TJ; Pandey RK
Photochem Photobiol; 2002 Nov; 76(5):555-9. PubMed ID: 12462653
[TBL] [Abstract][Full Text] [Related]
20. Rational engineering of semiconductor QDs enabling remarkable
Shen Y; Sun Y; Yan R; Chen E; Wang H; Ye D; Xu JJ; Chen HY
Biomaterials; 2017 Dec; 148():31-40. PubMed ID: 28961533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
